MedAvail Appoints Joan O’Rourke as President of SpotRx
May 24, 2021 at 08:00 am EDT
Share
MedAvail Holdings Inc. announced the appointment of Joan O’Rourke, RN, MSN, PNP to President of SpotRx. In this newly created role, Ms. O’Rourke will oversee the continued expansion and operation of the SpotRx in-clinic operations, reporting directly to Ed Kilroy, Chief Executive Officer. Prior to joining MedAvail, Ms. O’Rourke ran her own business, providing strategic consulting services to
large academic medical centers to stand up new pharmacy models and services for optimizing pharmacy drug
utilization, improving adherence and outcomes. She had previously spent 20 years at CVS Health. In her role as
Vice President of Coram Infusion Services, she was responsible for leading the specialty infusion strategy for
sales, customer operations and payor implementations. She has also held multiple senior positions across CVS
Health, with experiences in specialty pharmacy, home infusion, hospital, PBM, and retail sectors.
MedAvail Holdings, Inc. is a pharmacy technology and services company. The Company is focused on developing and commercializing a self-service pharmacy, mobile application, and kiosk. Its core technology and product, the MedAvail MedCenter (the MedCenter), is a pharmacist-controlled, patient-interactive, prescription dispensing system akin to a pharmacy in a box. It operates through two segments: Retail Pharmacy Services and Pharmacy Technology. The Retail Pharmacy Services segment operates as SpotRx, or the Pharmacy, which is a full-service retail pharmacy utilizing its automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment, through its MedAvail Technologies, Inc., develops and commercializes the MedCenter for direct sale or subscription to third-party customers, including some of the healthcare providers and systems, as well as large retail chains that provide full retail-pharmacy services using its technology.